ISSN : 0976-8505
A series of six Cu (II) complexes were prepared from N4 substituted thiosemicarbazones having structures [Cu (p-clbhtsc)2 ]Cl2. 2H2O [1], [Cu (p-mbhtsc)2]Cl2.2H2O [2], [Cu (p-nbhtsc)2]Cl2.2H2O [3], [Cu (p-clacehtsc)2 ]Cl2. 2H2O [4], [Cu (pmacehtsc) 2]Cl2.2H2O [5] and [Cu (p-nacehtsc)2]Cl2.2H2O [6] where (p-clbhtsc)=p-chlorobenzylidene thiosemicarbazone, (pmbhtsc)= p-methoxy benzylidene thiosemicarbazone, (p-nbhtsc)=p-nitro benzylidene thiosemicarbazone, (p-clacehtsc)=pchloroacetophenone thiosemicarbazone, (p-macehtsc)=p-methoxyacetophenone thiosemicarbazone, and (p-nacehtsc)=pnitroacetophenone thiosemicarbazone. All six complexes were characterized by elemental analysis, IR, 1HNMR, mass and electronic spectra. The magnetic moments and electronic spectral studies suggested distorted octahedral geometry for all the complexes. The monoanionic thiosemicarbazonate ligands act in a tridentate mode, binding through azomethine nitrogen and sulfur atom. Cytotoxic activity against human breast cancer cell line MCF-7, antibacterial and antioxidant activities were evaluated for all the six complexes. Out of the six Cu (II) complexes, five showed significant activity against the studied cell line; having IC50 values in the range 2-12 μM. The standard antibreast cancer drug Tamoxifen was used as a positive control. The synthesized compounds were screened for their in vitro antibacterial activity using Disc Diffusion method against two strains each of gram negative and gram positive bacteria. Tetracycline was used as positive control in the test. All the compounds showed significant antibacterial activity in the range of 2-10 mg/ml. Antioxidant activity of the six macrocyclic copper complexes was screened using the H2O2 scavenging assay. All six complexes exhibited potent antioxidant activity in the range 35-58%. The compounds would be evaluated further for their possible DNA binding, cleavage, antifungal and anti-diabetic activities.
Der Chemica Sinica received 6019 citations as per Google Scholar report